Guiyang Langma Information Technology Co., Ltd. 2025 Annual Report Summary Securities Code: 300288 Securities Abbreviation: Langma Information Announcement Number: 2026-019
Guiyang Langma Information Technology Co., Ltd. 2025 Annual Report Summary
I. Important Notice This annual report summary is derived from the full text of the annual report. To fully understand the company's operating results, financial status, and future development plans, investors should carefully read the full annual report text on the media designated by the China Securities Regulatory Commission. All directors attended the board meeting that reviewed this report. The audit opinion of Dahua Certified Public Accountants (Special General Partnership) on the company's financial report for the year is: Standard unqualified opinion. Non-standard audit opinion reminder □ Applicable ☑ Not applicable The company was not profitable at the time of listing and has not yet achieved profitability. □ Applicable ☑ Not applicable Board of Directors' review of the report period's profit distribution plan or capital reserve to share capital increase plan ☑ Applicable □ Not applicable The profit distribution plan reviewed and approved by the Board of Directors for the reporting period is: Based on 337,941,402 shares, a cash dividend of 0.1 yuan (tax inclusive) per 10 shares will be distributed to all shareholders, with 0 bonus shares (tax inclusive), and 0 shares will be converted from capital reserve to all shareholders per 10 shares. Board of Directors' resolution on the report period's preferred stock profit distribution plan □ Applicable ☑ Not applicable
1
II. Company Basic Information
-
Company Profile Stock Abbreviation Langma Information Stock Listing Exchange Shenzhen Stock Exchange Contact Person and Contact Information Name Board Secretary Wang Chun Securities Affairs Representative Xiao Yueyue Registered Address No. 31 Changling South Road, Jinyang Science and Technology Industrial Park, Guiyang National High-tech Industrial Development Zone, Guizhou Province (2nd Floor, National Digital Content Industry Park) No. 31 Changling South Road, Jinyang Science and Technology Industrial Park, Guiyang National High-tech Industrial Development Zone, Guizhou Province (2nd Floor, National Digital Content Industry Park) Fax 0851-83835538 0851-83842119 Email zhengquanbu@longmaster.com.cn zhengquanbu@longmaster.com.cn
-
Introduction to Main Business or Products in the Reporting Period In 2025, the company closely followed the business objectives set at the beginning of the year, adhering to the core development philosophy that "the essence of internet healthcare is still healthcare," and deeply cultivated the "Internet + Healthcare" field, actively promoting the market for the medical artificial intelligence product "39AI Doctor." Simultaneously, it continued to deepen its layout in core business areas such as medical health information services, medical services, internet-based specialty construction, and pharmaceutical e-commerce. During the reporting period, affected by unfavorable factors such as a decline in market demand, the revenue from the company's two main businesses, medical information services and mobile resale services, decreased year-on-year, leading to an overall decline in the company's operating revenue. In 2025, the company achieved operating revenue of 29,809.89 million yuan, a decrease of 21.36% compared to the same period last year. In 2024, due to the impairment of goodwill of 56,648.16 million yuan on the asset group formed by the acquisition of Qisheng Information's 100% equity, the net profit attributable to shareholders of the listed company on a consolidated basis resulted in a loss of 51,209.97 million yuan. In 2025, the company achieved a net profit attributable to shareholders of the listed company of 934.15 million yuan; simultaneously, the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 521.65 million yuan, achieving a turnaround from loss to profit year-on-year.
Langma Internet Healthcare Ecosystem
2